top of page
Search

MRCP Immunology: Hypersensitivity Types I–IV

TL;DR:

 In MRCP Part 1, hypersensitivity reactions are tested through mechanisms, timelines, and classic disease associations rather than immunology trivia. You must confidently differentiate Types I–IV, recognise prototype conditions, and avoid common traps such as confusing immune-complex disease with antibody-mediated cytotoxicity. This article provides a clear, exam-ready framework with examples and practical revision tips.


Why this matters

Immunology is a consistent scoring opportunity in MRCP Part 1, and hypersensitivity reactions are one of its most reliable themes. Questions are rarely theoretical; instead, they are embedded in clinical vignettes that test whether you understand mechanism, timing, and consequence.

Many candidates lose marks not because they lack knowledge, but because they blur the boundaries between the four types. This article focuses on what the examiners actually test, using a structured, clinician-led approach aligned with the MRCP(UK) curriculum. For wider context, begin with the MRCP Part 1 overview and then consolidate immunology using this guide.


Scope of hypersensitivity in MRCP Part 1

You are expected to know:

  • The Gell and Coombs classification (Types I–IV)

  • Core immune mediators (IgE, IgG, IgM, complement, T cells)

  • Time course of reactions

  • Prototype clinical conditions

  • Basic pathophysiological principles

You are not expected to memorise experimental cytokine pathways or niche molecular detail.


The four types of hypersensitivity — high-yield framework

Type I: Immediate (IgE-mediated)

  • Mechanism: Allergen cross-links IgE on mast cells → degranulation

  • Key mediators: Histamine, leukotrienes, prostaglandins

  • Timing: Seconds to minutes

  • Classic associations:

    • Anaphylaxis

    • Atopic asthma

    • Allergic rhinitis

    • Urticaria

Exam pearl: A raised serum tryptase supports mast-cell activation.

Type II: Antibody-mediated (cytotoxic or functional)

  • Mechanism: IgG or IgM directed against cell-surface or matrix antigens

  • Pathways: Complement activation or antibody-dependent cellular cytotoxicity

  • Timing: Hours to days

  • Classic associations:

    • Autoimmune haemolytic anaemia

    • Goodpasture syndrome

    • Myasthenia gravis (receptor blockade)

    • Graves’ disease (receptor stimulation)

Exam pearl: Functional disorders without cell destruction are still Type II.

Type III: Immune-complex mediated

  • Mechanism: Circulating antigen–antibody complexes deposit in tissues

  • Key feature: Complement activation and consumption

  • Timing: Days to weeks after exposure

  • Classic associations:

    • Serum sickness

    • Systemic lupus erythematosus

    • Post-streptococcal glomerulonephritis

    • Hypersensitivity pneumonitis

Exam pearl: Think systemic disease with low complement levels.

Type IV: Delayed (T-cell mediated)

  • Mechanism: Sensitised T lymphocytes release cytokines or cause cytotoxicity

  • Timing: 48–72 hours

  • Classic associations:

    • Contact dermatitis (e.g. nickel)

    • Tuberculin skin test

    • Type 1 diabetes mellitus

    • Multiple sclerosis

Exam pearl: No antibodies are involved — this is purely cell-mediated.


Comparison of hypersensitivity reaction types by immune mechanism and timing for MRCP Part 1.

Rapid comparison table (exam-friendly)

Type

Main mediator

Typical timing

Classic examples

I

IgE, mast cells

Minutes

Anaphylaxis, asthma

II

IgG/IgM

Hours–days

AIHA, Graves’

III

Immune complexes

Days–weeks

SLE, PSGN

IV

T cells

48–72 h

Contact dermatitis

Five most tested subtopics

  1. Anaphylaxis vs vasovagal syncope — bronchospasm and urticaria point to Type I

  2. Goodpasture vs lupus nephritis — linear (Type II) vs granular (Type III) deposition

  3. Graves’ disease — stimulatory antibodies (Type II)

  4. Tuberculin skin testing — delayed induration (Type IV)

  5. Serum sickness after drugs or antiserum — immune-complex disease


Practical example: mini-case

A 30-year-old man develops wheeze, hypotension, and widespread urticaria within minutes of receiving intravenous co-amoxiclav. Serum tryptase is elevated.

Question: What hypersensitivity mechanism explains this reaction?

Answer: IgE-mediated mast-cell degranulation (Type I hypersensitivity).

Why this scores:

  • Immediate onset

  • Systemic features

  • Objective evidence of mast-cell activation

This is a classic MRCP Part 1 stem.


Common pitfalls (and how to avoid them)

  • Confusing Type II and Type III because both involve antibodies

  • Forgetting that functional antibody disorders (e.g. Graves’) are Type II

  • Misclassifying contact dermatitis as IgE-mediated allergy

  • Ignoring time course clues in the stem

  • Over-analysing cytokine details not required for the exam


How to revise hypersensitivity efficiently

Practical study-tip checklist

  • □ Learn one prototype disease per type

  • □ Always identify whether antibodies or T cells are involved

  • □ Use timing as a discriminator

  • □ Reinforce patterns using Free MRCP MCQs

  • □ Test exam readiness with mock tests

For structured teaching, some candidates consolidate immunology further with targeted sessions in our lectures section.


FAQs

Which hypersensitivity type is most commonly tested in MRCP Part 1?

Types I and II are the most frequent, often appearing in clinical vignettes involving allergy or autoimmunity.

Is Type IV hypersensitivity antibody-mediated?

No. Type IV reactions are entirely T-cell mediated and delayed, with no antibody involvement.

How can I quickly distinguish Type II from Type III reactions?

Type II targets specific cell-surface antigens, whereas Type III involves circulating immune-complex deposition and often low complement levels.

Are cytokines tested in detail in MRCP Part 1?

No. Examiners focus on mechanisms, timing, and clinical associations rather than detailed cytokine profiles.

Where can I practise more hypersensitivity questions?

A dedicated MRCP QBank combined with timed mock tests is the most efficient approach.


Ready to start?

Hypersensitivity reactions are predictable, high-yield marks when revised properly. Consolidate this topic early, then integrate it with broader immunology using the MRCP Part 1 overview. Regular question practice and early testing will convert understanding into exam performance.


Sources

 
 
 

Comments

bottom of page